Trials / Not Yet Recruiting
Not Yet RecruitingNCT06307522
MRG-001 in Patients With Alcoholic Hepatitis
An Open-Label, Dose-Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of MRG-001 in Patients With Alcoholic Hepatitis
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- MedRegen LLC · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to test MRG-001 (an experimental medication). The purpose of this trial is to assess the dose related safety, Pharmacokinetics, and Pharmacodynamics of MRG-001 in patients with severe alcoholic hepatitis (AH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MRG-001 | Patients will receive subcutaneous administration of MRG-001 at designated visits. |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2026-09-01
- Completion
- 2026-12-01
- First posted
- 2024-03-13
- Last updated
- 2024-03-13
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06307522. Inclusion in this directory is not an endorsement.